Cargando…

Metformin use and prostate cancer risk: A meta-analysis of cohort studies

BACKGROUND: The relationship between metformin use and the risk of prostate cancer is still inconclusive. Therefore, we performed a systematic review and meta-analysis of all eligible cohort studies to evaluate a potential association of metformin use with prostate cancer risk. METHODS: A comprehens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Zhaohan, Zhou, Xiaofeng, Liu, Naibo, Wang, Jianfeng, Chen, Xing, Xu, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709307/ https://www.ncbi.nlm.nih.gov/pubmed/30896668 http://dx.doi.org/10.1097/MD.0000000000014955

Ejemplares similares

Prognostic role of platelet to lymphocyte ratio in prostate cancer: A meta-analysis
por: Wang, Jiangfeng, et al.
Publicado: (2018)

The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis
por: Xiao, Yao, et al.
Publicado: (2017)

Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies
por: Zhou, Xue-Liang, et al.
Publicado: (2017)

Effect of Metformin on Cancer Risk and Treatment Outcome of Prostate Cancer: A Meta-Analysis of Epidemiological Observational Studies
por: Yu, Hongliang, et al.
Publicado: (2014)

Metformin, Asian ethnicity and risk of prostate cancer in type 2 diabetes: a systematic review and meta-analysis
por: Chen, Christopher B., et al.
Publicado: (2018)

Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis
por: Yao, Long, et al.
Publicado: (2019)

Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients
por: Ma, Shujuan, et al.
Publicado: (2017)

Metformin Adjunct With Antineoplastic Agents for the Treatment of Lung Cancer: A Meta-Analysis of Randomized Controlled Trials and Observational Cohort Studies
por: Luo, Xiaofeng, et al.
Publicado: (2021)

Statin Use and the Risk of Prostate Cancer Biochemical Recurrence Following Definitive Therapy: A Systematic Review and Meta-Analysis of Cohort Studies
por: Sun, Jian-Xuan, et al.
Publicado: (2022)

Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study
por: Kuo, Yu‐Jui, et al.
Publicado: (2019)

Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort study
por: Nørgaard, Mette, et al.
Publicado: (2020)

The effect of metformin therapy on incidence and prognosis in prostate cancer: A systematic review and meta-analysis
por: He, Kancheng, et al.
Publicado: (2019)

Association of Statin Use with the Risk of Incident Prostate Cancer: A Meta-Analysis and Systematic Review
por: Xu, Meng-Yao, et al.
Publicado: (2022)

Vasectomy and prostate cancer risk: a meta-analysis of cohort studies
por: Shang, Yonggang, et al.
Publicado: (2015)

The impact of metformin use on the risk of prostate cancer after prostate biopsy in patients with high grade intraepithelial neoplasia
por: Dell'Atti, Lucio, et al.
Publicado: (2018)

Metformin Treatment Among Men With Diabetes and the Risk of Prostate Cancer: A Population-Based Historical Cohort Study
por: Freedman, Laurence S, et al.
Publicado: (2021)

Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor behind the Scene
por: Anwar, M. Akhtar, et al.
Publicado: (2014)

Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis
por: Chu, Danxia, et al.
Publicado: (2018)

Prognostic value of metformin in cancers: An updated meta-analysis based on 80 cohort studies
por: Yang, Jing, et al.
Publicado: (2022)

No significant association between immunosuppression in solid organ transplantation and prostate cancer risk: a meta-analysis of cohort studies
por: Bao, Ji-Ming, et al.
Publicado: (2019)

Effects of Metformin on Risk and Prognosis of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
por: Chen, Junhong, et al.
Publicado: (2023)

Periodontal disease and the risk of prostate cancer: a meta-analysis of cohort studies
por: Guo, Zhenlang, et al.
Publicado: (2021)

Breast cancer risk for women with diabetes and the impact of metformin: A meta‐analysis
por: Lu, Yifan, et al.
Publicado: (2022)

Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population‐based cohort study in Korea with systematic review and meta‐analysis
por: Seo, Seung In, et al.
Publicado: (2021)

Metformin Use and Mortality in Women with Ovarian Cancer: An Updated Meta-Analysis
por: Guo, Mingchuan, et al.
Publicado: (2022)

Coffee consumption and risk of cancers: a meta-analysis of cohort studies
por: Yu, Xiaofeng, et al.
Publicado: (2011)

Cancer Risk in HBV Patients With Statin and Metformin Use: A Population-Based Cohort Study
por: Chen, Chang-I., et al.
Publicado: (2015)

lncRNA-UCA1 in the diagnosis of bladder cancer: A meta-analysis
por: Ding, Zhenshan, et al.
Publicado: (2021)

Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER
por: Joshua, Anthony M., et al.
Publicado: (2022)

Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis
por: Liu, Chen-Qian, et al.
Publicado: (2022)

Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis
por: He, Xing-kang, et al.
Publicado: (2016)

Legume intake and risk of prostate cancer: a meta-analysis of prospective cohort studies
por: Li, Jie, et al.
Publicado: (2017)

Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
por: Noto, Hiroshi, et al.
Publicado: (2012)

A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer
por: Lee, Chung-Shien, et al.
Publicado: (2023)

Diagnostic ability of %p2PSA and prostate health index for aggressive prostate cancer: a meta-analysis
por: Wang, Wenying, et al.
Publicado: (2014)

Risk of prostate cancer in relatives of prostate cancer patients in Sweden: A nationwide cohort study
por: Xu, Xing, et al.
Publicado: (2021)

The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis
por: Yao, Xiangyang, et al.
Publicado: (2021)

GSTP1 Ile105Val Polymorphism and Prostate Cancer Risk: Evidence from a Meta-Analysis
por: Wei, Bingbing, et al.
Publicado: (2013)

Hypertension and risk of prostate cancer: a systematic review and meta-analysis
por: Liang, Zhen, et al.
Publicado: (2016)

The relationship between the use of metformin and the risk of pancreatic cancer in patients with diabetes: a systematic review and meta-analysis
por: Hu, Jian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_as2stlt7g3vl5so4eht0lj6g4b